Fig. 3

Antitumor efficacy. A BOR of partial response was observed in 1 patient with PD-1–refractory squamous NSCLC. a Waterfall plot of best percent change from baseline in the SLD for target lesions, full analysis set, with BOR indicated for each patient. b Spider plot of percent change from baseline in SLD for target lesions over time, full analysis set. c Baseline and post-treatment scan images. The baseline scan was taken ~ 4 weeks prior to treatment initiation. The post-treatment scan was taken at ~ 7 weeks after treatment initiation. Arrows point to tumor location in right lower lobe of the lung. CRC, colorectal cancer; NSCLC, non–small-cell lung cancer; PD-1, programmed cell death 1; SCCHN, squamous cell cancer of the head and neck; SLD, sum of the longest diameter